Mulmit

LIGAND PHARMACEUTICALS INCLIGAND PHARMACEUTICALS INC

LGND Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31268,087,00041,002,000124,453,0006.13
2024-12-31167,133,000-22,606,000-4,032,000-0.22
2023-12-31131,314,00011,942,00052,154,0002.94
2022-12-31196,245,0003,037,000-33,361,000-1.98
2021-12-31241,544,000103,851,00057,138,0003.31

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-03Reardon AndrewCLO & Secretary300
2026-09-03Reardon AndrewCLO & Secretary1,800
2026-09-03Reardon AndrewCLO & Secretary2,115
2026-09-03Reardon AndrewCLO & Secretary385
2026-09-03Reardon AndrewCLO & Secretary400
2026-08-12Espinoza OctavioChief Financial Officer16,179
2026-08-12Espinoza OctavioChief Financial Officer2,074
2026-08-12Espinoza OctavioChief Financial Officer2,869
2026-08-12Espinoza OctavioChief Financial Officer7,171
2026-08-12Espinoza OctavioChief Financial Officer3,348
2026-08-12Espinoza OctavioChief Financial Officer31,641
2026-08-12Espinoza OctavioChief Financial Officer2,869

8-K events

FiledItems
2026-09-02Financial statements and exhibits
2026-08-06Results of operations · Financial statements and exhibits
2026-07-14Entry into a material agreement · Completed acquisition or disposition of assets · Creation of a direct financial obligation · Regulation FD disclosure · Financial statements and exhibits
2026-06-25Entry into a material agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Other events · Financial statements and exhibits
2026-06-22Entry into a material agreement · Other events · Financial statements and exhibits
2026-06-09Officer or director change · Submission of matters to a vote
2026-05-18Entry into a material agreement · Financial statements and exhibits
2026-05-07Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.